[Robert: paste actual Google Review quote — filtered to mention this page's topic]
[Robert: First name + initial]
[Robert: month year of review]
STEP-1 established the modern GLP-1 era for weight management. Semaglutide at the 2.4-milligram weekly dose (marketed as Wegovy) achieved 14.9 percent mean body-weight loss at 68 weeks in 1,961 adults with obesity. The Phase 3 randomized controlled trial was published in the New England Journal of Medicine in March 2021 (Wilding JPH et al, NEJM 2021;384:989-1002). Follow-on SELECT trial added cardiovascular benefit, leading to FDA approval for cardiovascular risk reduction.
Treatments supervised by Dr. Kenika Norrachetdecha
Medical Director · Thai License #72509
● Mon–Sat 8 AM–6 PM · Online consults daily · Reply in 2 Min
Personal consultation included with every program
That's −17.8 kg — you'd weigh .
Based on the 20.9% trial-mean. Individual outcomes vary.STEP-1 is the pivotal phase-3 trial of semaglutide 2.4 mg for chronic weight management. Its results led directly to the FDA approval of Wegovy in 2021.
Adults with overweight or obesity, without type 2 diabetes — isolating the weight-loss effect of semaglutide 2.4 mg from any glycemic confounder.
Weekly subcutaneous semaglutide, escalated every 4 weeks to minimise GI side-effects. The same titration ladder is used in clinical practice today.
Semaglutide 2.4 mg produced a six-fold greater mean weight loss versus placebo over 68 weeks — the largest single-agent phase-3 weight-loss effect reported at the time of publication.
Safety in STEP-1 mirrored the established GLP-1 class profile — transient gastrointestinal events dominating the first months and resolving as patients reached maintenance dose.
Three implications still shape how semaglutide 2.4 mg is prescribed today — including in TRT Bangkok's Wegovy program.
14.9% mean weight loss was the largest phase-3 single-agent obesity-trial result published at the time — the benchmark that subsequent trials had to beat.
STEP-1 led directly to the June 2021 FDA approval of Wegovy (semaglutide 2.4 mg) for chronic weight management in adults with obesity or overweight + comorbidity.
STEP-1 became the reference comparator for every subsequent weight-loss trial — including the head-to-head SURMOUNT-5 study of tirzepatide vs semaglutide.
Pick your treatment, enter your weights, see your trajectory. All data from peer-reviewed clinical trials. Individual outcomes vary — final program plan determined in private consultation.
Your trajectory · based on clinical-trial mean
STEP-1 reference: Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. STEP-2 through STEP-5 expanded results: STEP-2 (T2D patients, -9.6 percent), STEP-3 (intensive behavioral therapy, -16.0 percent), STEP-4 (maintenance, additional 7.9 percent loss with continuation), STEP-5 (104-week, -15.2 percent sustained). SELECT (NEJM 2023) showed 20 percent reduction in major adverse cardiovascular events over 5 years.
Each program is personalized based on your profile, medical history, and goals.
Step 1 of 5
Step 2 of 5
Select all that apply, or "None of these"
Step 3 of 5
Confidential — only your doctor sees this
Step 4 of 5
Step 5 of 5
Dr. Kenika's recommendation for you
Your access
—
Our actual clinic · Real photos
Authentic medications. Direct access to Dr. Kenika. Comprehensive metabolic care beyond GLP-1 alone.
Authentic Medications
Mounjaro, Zepbound (Eli Lilly), Wegovy, Ozempic, Saxenda (Novo Nordisk) — all sourced through the licensed Thai pharmaceutical supply chain.
Direct Doctor Access
WhatsApp Dr. Kenika directly. Every GLP-1 prescription personally supervised by the Medical Director.
Beyond GLP-1
Multi-modal metabolic care: GLP-1 plus hormone optimization, IV recovery, and advanced peptide protocols.
In Thailand for treatment? Translate the STEP-1 results into your personal protocol — schedule an in-person Pattaya consult with Dr. Kenika and start the same week.
STEP-1 (Semaglutide Treatment Effect in People with obesity) is a Phase 3 randomized controlled trial of weekly semaglutide 2.4 mg (Wegovy) for chronic weight management. Published in NEJM March 2021 (Wilding JPH et al, NEJM 2021;384:989-1002).
1,961 adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) plus one weight-related condition, EXCLUDING type 2 diabetes. Mean baseline weight 105.3 kg, mean BMI 37.9. 74.1% female. Most had at least one comorbidity.
Semaglutide 2.4 mg weekly subcutaneous injection vs placebo. Dose escalation over 16 weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg). All participants received lifestyle counseling. Treatment duration: 68 weeks.
Mean percent change in body weight at week 68: −14.9% with semaglutide vs −2.4% with placebo. Difference: −12.4 percentage points (95% CI −13.4 to −11.5, P<0.001). 86.4% of semaglutide patients achieved ≥5% weight loss; 50.5% achieved ≥15%.
Most common: nausea (44.2%), diarrhea (31.5%), vomiting (24.8%), constipation (23.4%). Most mild-to-moderate, occurring during titration. Discontinuation due to adverse events: 7.0% (semaglutide) vs 3.1% (placebo). Gallbladder disorders: 2.6% vs 1.2%.
The SELECT trial (2023, NEJM) followed STEP-1 — randomized 17,604 patients with obesity and pre-existing cardiovascular disease (no diabetes) to semaglutide 2.4 mg vs placebo for ~5 years. Result: 20% reduction in major adverse cardiovascular events. Wegovy now FDA-approved for CV risk reduction.
Yes. STEP-2 (T2D patients): −9.6% weight loss. STEP-3 (intensive behavioral therapy): −16.0%. STEP-4 (maintenance): patients who continued semaglutide lost additional 7.9%; those who switched to placebo regained 6.9%. STEP-5 (2-year): −15.2% sustained at 104 weeks.
SURMOUNT-1 (tirzepatide 15 mg, 72 weeks): −20.9% weight loss. STEP-1 (semaglutide 2.4 mg, 68 weeks): −14.9%. Tirzepatide produced ~40% greater weight loss. The SURMOUNT-5 head-to-head trial (2025) confirmed tirzepatide's superiority in direct comparison.
Licensed
Thai Pharmacy
Pharmaceutical
Grade
Doctor
Supervised
Same-Day
Care
Real reviews from real patients on Google Business Profile. Currently 5.0 ★ from 15 verified reviews — and growing. Reviews are updated regularly.
[Robert: paste actual Google Review quote — filtered to mention this page's topic]
[Robert: paste actual Google Review quote — filtered to mention this page's topic]
[Robert: paste actual Google Review quote — filtered to mention this page's topic]
Peer-reviewed primary sources, FDA prescribing information, and manufacturer documentation.
Additional clinical questions are discussed during your private consultation with Dr. Kenika.
Direct access to Dr. Kenika. Authentic medications. Three access points across Thailand.
Personal medical supervision · Cancel anytime · Authentic medications from Eli Lilly and Novo Nordisk
Book via WhatsApp · Free eligibility check
Each GLP-1 protocol has a different mechanism, trial profile, and outcome ceiling. Compare or explore by location.
Eli Lilly's dual GIP/GLP-1 agonist. Highest trial-mean of any approved GLP-1. Best fit for goals above 15%.
See program →
Novo Nordisk's most-prescribed GLP-1. Excellent track record for goals up to 15%. Built-in outcome estimator.
See program →
Investigational GLP-1/GIP/Glucagon triple agonist. Highest documented mean reduction. Private-consultation program.
See program →
In-person consultation, baseline labs, and same-week start. Walk-in or appointment. Most international patients begin here.
See clinic →The STEP-1 trial (Wilding et al., New England Journal of Medicine 2021) enrolled 1,961 adults with overweight or obesity over 68 weeks at 129 international sites. Participants receiving semaglutide 2.4mg subcutaneously weekly achieved a mean weight reduction of 14.9 percent versus 2.4 percent with placebo. 86.4 percent of semaglutide participants achieved 5 percent or greater weight loss versus 31.5 percent in the placebo arm, with 50.5 percent achieving 15 percent or more weight loss. The trial established semaglutide as the first GLP-1 receptor agonist to demonstrate weight loss approaching bariatric surgery thresholds.
Last reviewed by Dr. Kenika Tonkam, Medical Director, TRT Bangkok · June 3, 2026
' + eyebrows[toolKey] + '
' + '' + taglines[toolKey] + '
' + '' + WA_ICON + '' + initialText + ' →' + '' + /* v33: microcopy removed — green CTA is self-evidently WhatsApp + status below has all the context */ 'Free consultation · ' + replyTimingShort() + ' · no spam
' + ''; /* Live-update CTA when tool state changes (best-effort via polling) */ var ctaA = wrap.querySelector('[data-track-one]'); var ctaLabel = wrap.querySelector('[data-cta-label]'); var lastCtxStr = JSON.stringify(initialCtx); setInterval(function() { var ctx = readToolContext(toolKey); var cs = JSON.stringify(ctx); if (cs === lastCtxStr) return; lastCtxStr = cs; var newText = buildCTAText(toolKey, ctx); var newMsg = buildPrefilledMessage(toolKey, ctx, pageTopic); ctaA.href = 'https://wa.me/' + WA_NUMBER + '?text=' + encodeURIComponent(newMsg); ctaLabel.textContent = newText + ' →'; }, 1500); /* Track-1 click event */ ctaA.addEventListener('click', function() { if (typeof gtag === 'function') { gtag('event', 'wl_v2_track1_click', { tool: toolKey, page: location.pathname }); } }); /* Track-2 submit */ var form = wrap.querySelector('form'); form.addEventListener('submit', function(e) { e.preventDefault(); var btn = form.querySelector('button'); var status = wrap.querySelector('.trt-wl-v2-status'); var cc = form.cc.value; var phoneRaw = (form.phone.value || '').replace(/[^0-9]/g, ''); if (phoneRaw.length < 6) { status.textContent = 'Please enter a valid phone number.'; status.style.color = '#FCD34D'; return; } var fullPhone = cc + ' ' + phoneRaw; btn.disabled = true; btn.textContent = 'Sending…'; status.style.color = '#FFFFFF'; status.textContent = ''; var ctx = readToolContext(toolKey); var payload = { location: 'wl-v2-' + toolKey, name: '', email: '', whatsapp: fullPhone, phone: fullPhone, country_code: cc, current_weight: ctx.current_weight || '', goal_weight: ctx.goal_weight || '', preferred_drug: ctx.drug || ctx.match || '', tool: toolKey, tool_context: JSON.stringify(ctx), page: location.pathname.replace(/^\//, '').replace(/\/$/, ''), page_type: document.body.dataset.pageType || 'wl-spoke', page_topic: pageTopic, referrer: document.referrer || '', source_url: location.href }; var fetchPromise = ENDPOINT ? fetch(ENDPOINT, { method: 'POST', mode: 'no-cors', headers: { 'Content-Type': 'text/plain;charset=utf-8' }, body: JSON.stringify(payload) }).then(function() { return true; }).catch(function() { return false; }) : Promise.resolve(false); fetchPromise.then(function(ok) { if (typeof gtag === 'function') { gtag('event', 'wl_v2_track2_submit', { tool: toolKey, page: location.pathname, ok: ok }); } status.style.color = '#0F6E56'; status.textContent = isClinicOpenNow() ? '✓ Thanks! We\'ll WhatsApp you within minutes. Opening WhatsApp now…' : '✓ Thanks! We\'ll WhatsApp you within 2 hours. Opening WhatsApp now…'; btn.textContent = '✓ Sent'; /* Also open WhatsApp for the user — high-intent flow */ var msg = buildPrefilledMessage(toolKey, ctx, pageTopic) + ' My number: ' + fullPhone + '.'; var waUrl = 'https://wa.me/' + WA_NUMBER + '?text=' + encodeURIComponent(msg); setTimeout(function() { window.open(waUrl, '_blank'); }, 600); }); }); return wrap; } /* ============================================================ * 3) Read live tool state — best-effort DOM scraping per tool * ============================================================ */ function readToolContext(toolKey) { if (toolKey === 'wow-stat') { var sec = document.getElementById('wow-stat'); if (!sec) return {}; var nums = sec.querySelectorAll('input[type="number"], input[type="text"]'); var cur = nums.length ? parseFloat(nums[0].value) : null; /* Look for goal weight in displayed text like "you'd weigh 67.2 kg" */ var txt = sec.textContent || ''; var m = txt.match(/(\d+(?:\.\d+)?)\s*kg/g); var goal = null; if (m && m.length) { var nums2 = m.map(function(s) { return parseFloat(s); }); /* The smaller number in the section after "weigh" is likely the goal */ var weighIdx = txt.search(/weigh\s*$/i); var idx = txt.search(/weigh\s+/i); if (idx > -1) { var after = txt.slice(idx + 5); var gm = after.match(/(\d+(?:\.\d+)?)\s*kg/); if (gm) goal = parseFloat(gm[1]); } } return { current_weight: cur && !isNaN(cur) ? cur : null, goal_weight: goal, drug: 'Mounjaro' /* WOW-Stat on hub is Mounjaro-focused */ }; } if (toolKey === 'estimator') { var sec2 = document.getElementById('estimator'); if (!sec2) return {}; /* Find selected drug tab (visually highlighted button) */ var drug = null; var btns = sec2.querySelectorAll('button, [role="tab"], div[data-drug]'); for (var i = 0; i < btns.length; i++) { var b = btns[i]; var bg = window.getComputedStyle(b).backgroundColor; var txt2 = (b.textContent || '').trim(); if (/^(Mounjaro|Wegovy|Retatrutide|Tirzepatide|Ozempic|Semaglutide|Saxenda|Zepbound)$/i.test(txt2.split('\n')[0])) { if (bg && bg !== 'rgba(0, 0, 0, 0)' && bg !== 'transparent') { /* heuristic: dark blue = selected */ if (/24, 95, 165|29, 51, 91|0, 100|29,51,91/.test(bg.replace(/\s/g, ''))) { drug = txt2.split('\n')[0].trim(); break; } } if (!drug) drug = txt2.split('\n')[0].trim(); } } var inputs = sec2.querySelectorAll('input[type="number"], input[type="text"]'); var cw = inputs.length > 0 ? parseFloat(inputs[0].value) : null; var gw = inputs.length > 1 ? parseFloat(inputs[1].value) : null; return { drug: drug || 'Mounjaro', current_weight: cw && !isNaN(cw) ? cw : null, goal_weight: gw && !isNaN(gw) ? gw : null }; } if (toolKey === 'quiz') { var sec3 = document.getElementById('quiz'); if (!sec3) return {}; var matchTxt = sec3.textContent.match(/Your\s+(?:match|recommendation)[\s:]+([A-Za-z][A-Za-z\s\-]+?)(?:\.|$|\n)/i); return { match: matchTxt ? matchTxt[1].trim() : null }; } return {}; } /* ============================================================ * v30: Hub-Quiz → Teaser-CTA (replaces inline quiz on hub-page) * Inside section#quiz: hide quiz form/steps, inject single CTA * that links to /weight-loss-calculator/ * ============================================================ */ function injectQuizTeaser() { var sec = document.getElementById('quiz'); if (!sec) return false; if (sec.querySelector('.trt-quiz-teaser-cta')) return true; /* already injected */ /* Hide quiz form content but keep heading + sub */ var hideStyle = document.createElement('style'); hideStyle.id = 'trt-hub-quiz-hide'; hideStyle.textContent = [ /* hide all step content + back/next buttons inside #quiz, keep only the heading area */ '#quiz [class*="step-"], #quiz .step, #quiz [class*="quiz-step"]{display:none!important;}', /* hide any input/select/button/form inside #quiz */ '#quiz form, #quiz input, #quiz select, #quiz button:not(.trt-quiz-teaser-cta), #quiz .nav-row, #quiz .progress-bar{display:none!important;}', /* hide nested div containers that hold the quiz form (heuristic: divs with multiple inputs as descendants) */ '#quiz > div > div:has(input), #quiz > div > div:has(select){display:none!important;}' ].join('\n'); document.head.appendChild(hideStyle); /* Build the CTA */ var ctaWrap = document.createElement('div'); ctaWrap.className = 'trt-quiz-teaser-wrap'; ctaWrap.style.cssText = 'max-width:560px;margin:24px auto 0;padding:0 20px;text-align:center;'; ctaWrap.innerHTML = '' + 'Start Your 2-Minute Assessment →' + 'Reviewed by Dr. Kenika Norrachetdecha, MD · Thai License #72509
'; /* Append directly to the section (most robust against React re-render) */ sec.appendChild(ctaWrap); /* Hover handler */ var cta = ctaWrap.querySelector('a'); cta.addEventListener('mouseenter', function() { cta.style.background = '#2A4A7F'; }); cta.addEventListener('mouseleave', function() { cta.style.background = '#1D335B'; }); cta.addEventListener('click', function() { if (typeof gtag === 'function') gtag('event', 'wl_hub_quiz_teaser_click', { destination: '/weight-loss-calculator/' }); }); return true; } /* ============================================================ * 4) Inject modules as siblings AFTER each tool section * v39: Back to sibling-inject (React-safe), but with section-background-bridge * via injected CSS that extends the tool-section visual into the v2-modul. * ============================================================ */ /* ============================================================ * v49: Runtime width-sync — kein CSS-calc-Glücksspiel mehr. * Measure inner card's actual bounding rect → apply identical * width + left-offset to v2 module via inline-style. * Adapts to ANY viewport (320px → 4K), survives React re-renders, * and survives Site-CSS conflicts since inline-style wins. * ============================================================ */ function syncCardWidths() { var pairs = [ { sectionId: 'wow-stat', innerSel: ':scope > div' }, { sectionId: 'estimator', innerSel: ':scope > div > div.bg-white' } ]; var wowInnerRect = null; /* v50: capture wow-stat inner for trust-bar sync */ pairs.forEach(function(p) { var sec = document.getElementById(p.sectionId); if (!sec) return; var inner = sec.querySelector(p.innerSel); var v2 = document.querySelector('.trt-wl-v2[data-tool="' + p.sectionId + '"]'); if (!inner || !v2) return; var innerRect = inner.getBoundingClientRect(); if (p.sectionId === 'wow-stat') wowInnerRect = innerRect; /* offsetLeft of inner relative to v2's parent (= section's parent = body usually) */ var v2ParentRect = v2.parentNode.getBoundingClientRect(); var leftOffset = innerRect.left - v2ParentRect.left; var width = innerRect.width; /* Apply via inline-style — beats all CSS-cascade */ v2.style.setProperty('width', width + 'px', 'important'); v2.style.setProperty('max-width', width + 'px', 'important'); v2.style.setProperty('margin-left', leftOffset + 'px', 'important'); v2.style.setProperty('margin-right', '0', 'important'); /* Also sync background of section to body bg, kill any divider borders */ sec.style.setProperty('background', 'rgb(240, 245, 250)', 'important'); sec.style.setProperty('border-top', '0', 'important'); sec.style.setProperty('border-bottom', '0', 'important'); }); /* v50: sync .page-trust-bar width + leftOffset to match wow-stat inner card (third shell of ONE-CARD) */ if (wowInnerRect) { var trustBar = document.querySelector('.page-trust-bar'); if (trustBar) { var tbParentRect = trustBar.parentNode.getBoundingClientRect(); var tbLeftOffset = wowInnerRect.left - tbParentRect.left; trustBar.style.setProperty('width', wowInnerRect.width + 'px', 'important'); trustBar.style.setProperty('max-width', wowInnerRect.width + 'px', 'important'); trustBar.style.setProperty('margin-left', tbLeftOffset + 'px', 'important'); trustBar.style.setProperty('margin-right', '0', 'important'); } /* v50: also kill page-trust-bar-wrap inline border-top/bottom + sync bg */ var tbWrap = document.querySelector('section.page-trust-bar-wrap'); if (tbWrap) { tbWrap.style.setProperty('background', 'rgb(240, 245, 250)', 'important'); tbWrap.style.setProperty('border-top', '0', 'important'); tbWrap.style.setProperty('border-bottom', '0', 'important'); tbWrap.style.setProperty('padding-top', '0', 'important'); tbWrap.style.setProperty('padding-bottom', '0', 'important'); tbWrap.style.setProperty('margin-top', '0', 'important'); } } } /* ============================================================ * v53 · HERO DE-CLUTTER (SICHERE Version — exakte DOM-Targets statt blindes text-content match) * Hide redundant trust signals + distractors that duplicate the page-trust-bar 2000px below. * v52 ROLLBACK: text-content match war zu breit, hat Parent-Hero erwischt. * v53 Fix: spezifische class-Anforderungen + children-count guards + text-length guards. * ============================================================ */ function hideHeroNoise() { /* T1: Bullet trust list parent — div.flex.flex-col mit EXAKT 3 children wobei first child mit "Authentic Mounjaro" beginnt. KANN unmöglich Hero-Parent treffen. */ document.querySelectorAll('div.flex.flex-col').forEach(function(div) { if (div.__trtHidden) return; if (div.children.length !== 3) return; var firstChildText = (div.children[0].innerText || '').trim(); if (firstChildText.indexOf('Authentic Mounjaro') === 0) { div.style.setProperty('display', 'none', 'important'); div.__trtHidden = true; } }); /* v54: T2 (Doctor block) RAUS — Dr. Kenika mit rundem Foto ist wichtiger Authority/Humanization-Trust-Signal, bleibt sichtbar. */ /* T3: Mon-Sat status — p.font-body mit "Mon" + ("AM"|"Sat") — sehr spezifisch, kein anderes p hat genau diese kombo. */ document.querySelectorAll('p.font-body').forEach(function(p) { if (p.__trtHidden) return; var t = p.innerText || ''; if (t.indexOf('Mon') >= 0 && (t.indexOf('AM') >= 0 || t.indexOf('Sat') >= 0)) { p.style.setProperty('display', 'none', 'important'); p.__trtHidden = true; } }); } function inject() { injectHideCSS(); /* v52: hero de-clutter (run early so user sees clean hero ASAP) */ hideHeroNoise(); /* Quiz: replace with teaser CTA to /weight-loss-calculator/ */ injectQuizTeaser(); /* Tools: inject AFTER wow-stat + estimator as siblings */ var tools = ['wow-stat', 'estimator']; tools.forEach(function(key) { var sec = document.getElementById(key); if (!sec) return; /* v46: kill whitespace-only text nodes inside section that create the 3px trailing gap */ Array.prototype.slice.call(sec.childNodes).forEach(function(n) { if (n.nodeType === 3 && !(n.textContent && n.textContent.trim())) { n.parentNode.removeChild(n); } }); /* v47/v48/v49: inline-style overrides — beats site's higher-specificity rules. */ sec.style.setProperty('background', 'rgb(240, 245, 250)', 'important'); sec.style.setProperty('border-top', '0', 'important'); sec.style.setProperty('border-bottom', '0', 'important'); /* Skip if module already a sibling */ if (sec.nextElementSibling && sec.nextElementSibling.classList && sec.nextElementSibling.classList.contains('trt-wl-v2') && sec.nextElementSibling.getAttribute('data-tool') === key) return; var mod = buildModule(key); if (sec.parentNode) { sec.parentNode.insertBefore(mod, sec.nextSibling); } }); /* Remove any existing v2-module that was previously injected under #quiz */ var oldQuizMod = document.querySelector('.trt-wl-v2[data-tool="quiz"]'); if (oldQuizMod) oldQuizMod.remove(); /* v49: width-sync after inject — schedule multiple times to catch late layout shifts */ syncCardWidths(); [50, 200, 600, 1500, 3000].forEach(function(ms) { setTimeout(syncCardWidths, ms); setTimeout(hideHeroNoise, ms); /* v52: re-apply hide after potential React re-render */ }); /* v60: sticky-CTA visibility manager — hide bottom sticky when any baby-blue in-page CTA visible */ setTimeout(initStickyCtaObserver, 1000); /* v63: JS-driven press feedback (CSS :active was beaten by v51 cascade-war) */ setTimeout(initPressFeedback, 800); /* v66: fix Tailwind bracket-class SVG widths (w-[22px] etc. render as 0 width) */ fixBrokenSvgIcons(); [100, 500, 1500, 3000].forEach(function(ms) { setTimeout(fixBrokenSvgIcons, ms); }); } /* ============================================================ * v66 · Fix broken Tailwind bracket-class SVG widths * SVGs with class="w-[22px] h-[22px]" sometimes render at 0×0 * (Tailwind brackets not always parsed by the runtime CSS). * Solution: parse the class, set width/height attributes directly * on the SVG element — HTML attributes beat CSS for SVG sizing. * ============================================================ */ function fixBrokenSvgIcons() { var svgs = document.querySelectorAll('svg[class*="w-["], svg[class*="h-["]'); svgs.forEach(function(svg) { if (svg.__trtSvgFixed) return; var cls = svg.getAttribute('class') || ''; var wm = cls.match(/w-\[(\d+)px\]/); var hm = cls.match(/h-\[(\d+)px\]/); if (wm) svg.setAttribute('width', wm[1]); if (hm) svg.setAttribute('height', hm[1]); if (wm || hm) { svg.style.setProperty('width', (wm ? wm[1] : (hm ? hm[1] : '24')) + 'px', 'important'); svg.style.setProperty('height', (hm ? hm[1] : (wm ? wm[1] : '24')) + 'px', 'important'); svg.style.setProperty('flex-shrink', '0', 'important'); svg.__trtSvgFixed = true; } }); } /* ============================================================ * v65 · JS-driven Press Feedback (PRONOUNCED scale + 150ms hold) * pointerdown → scale(0.85) + dark bg overlay via inline !important * pointerup → animate back (snappy 0.18s ease-out) * Uses element.animate() Web Animations API as backup if transition fails. * ============================================================ */ function initPressFeedback() { if (window.__trt_press_init) return; window.__trt_press_init = true; var SELECTORS = [ '.trt-quiz-teaser-cta', '.trt-hero-cta', 'a.wa-cta', '.trt-wl-v2-cta', 'a[class*="border-white"][class*="rounded-"]', 'a[class*="bg-[#8DBFE2]"][class*="rounded-"]', ].join(','); var pressed = null; var minHoldTime = 150; /* ms — minimum visual press time so user sees it */ function addPress(e) { var t = e.target.closest(SELECTORS); if (!t) return; if (pressed && pressed.el === t) return; pressed = { el: t, startTime: performance.now() }; /* Disable existing transition first so the scale change is INSTANT */ t.style.setProperty('transition', 'none', 'important'); t.style.setProperty('transform', 'scale(0.85)', 'important'); t.style.setProperty('opacity', '0.80', 'important'); t.style.setProperty('filter', 'brightness(0.85)', 'important'); /* Force reflow to commit the no-transition + scale state */ void t.offsetHeight; } function releaseNow(p) { /* now turn transition back on for SMOOTH return */ p.el.style.setProperty('transition', 'transform 0.22s cubic-bezier(.34,1.56,.64,1), opacity 0.22s ease, filter 0.22s ease', 'important'); p.el.style.removeProperty('transform'); p.el.style.removeProperty('opacity'); p.el.style.removeProperty('filter'); /* cleanup transition override after return animation completes */ setTimeout(function() { p.el.style.removeProperty('transition'); }, 240); } function removePress() { if (!pressed) return; var p = pressed; pressed = null; /* Ensure minimum hold time so user perceives press visually */ var elapsed = performance.now() - p.startTime; var wait = Math.max(0, minHoldTime - elapsed); setTimeout(function() { releaseNow(p); }, wait); } document.addEventListener('pointerdown', addPress, { passive: true }); document.addEventListener('pointerup', removePress, { passive: true }); document.addEventListener('pointercancel', removePress, { passive: true }); document.addEventListener('touchend', removePress, { passive: true }); document.addEventListener('touchcancel', removePress, { passive: true }); document.addEventListener('mouseup', removePress, { passive: true }); } /* ============================================================ * v60 · Sticky-CTA Visibility Manager * CRO best-practice (Hims/Apple): hide the bottom sticky-cta * when an in-page primary CTA (baby-blue) is visible — no * decision-paralysis from two competing CTAs on screen. * ============================================================ */ function initStickyCtaObserver() { if (window.__trt_sticky_obs) return; /* idempotent */ var sticky = document.querySelector('.sticky-cta'); if (!sticky) return; /* Watch all v2-modules (each has a baby-blue CTA inside) */ var watch = Array.prototype.slice.call(document.querySelectorAll('.trt-wl-v2')); if (!watch.length) return; var visibleSet = new Set(); function updateSticky() { if (visibleSet.size > 0) { sticky.style.setProperty('opacity', '0', 'important'); sticky.style.setProperty('pointer-events', 'none', 'important'); sticky.style.setProperty('transform', 'translateY(100%)', 'important'); } else { sticky.style.removeProperty('opacity'); sticky.style.removeProperty('pointer-events'); sticky.style.removeProperty('transform'); } } var obs = new IntersectionObserver(function(entries) { entries.forEach(function(e) { if (e.isIntersecting && e.intersectionRatio > 0.4) { visibleSet.add(e.target); } else { visibleSet.delete(e.target); } }); updateSticky(); }, { threshold: [0, 0.4, 1] }); watch.forEach(function(el) { obs.observe(el); }); window.__trt_sticky_obs = obs; } /* v49: Re-sync on viewport changes (orientation, resize) and on React re-renders */ window.addEventListener('resize', function() { /* debounce */ clearTimeout(window.__trt_wl_v2_resize_t); window.__trt_wl_v2_resize_t = setTimeout(syncCardWidths, 100); }); window.addEventListener('orientationchange', function() { setTimeout(syncCardWidths, 200); }); /* Observe DOM mutations on wow-stat and estimator sections to catch React re-renders */ if (typeof MutationObserver !== 'undefined') { var mo = new MutationObserver(function() { clearTimeout(window.__trt_wl_v2_mo_t); window.__trt_wl_v2_mo_t = setTimeout(syncCardWidths, 50); }); setTimeout(function() { ['wow-stat', 'estimator'].forEach(function(id) { var el = document.getElementById(id); if (el) mo.observe(el, { childList: true, subtree: true, attributes: true, attributeFilter: ['style', 'class'] }); }); }, 1500); } if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', inject); } else { inject(); } /* Re-run after React-hydration in case tools render late */ setTimeout(inject, 800); setTimeout(inject, 2000); })();